Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-25 @ 2:14 PM
NCT ID:
NCT02988466
Group ID:
EG002
Title:
Arm C: Haplo-HCT HCT-CI ≤2 Aged ≥55 and < 65yo
Description:
Reduced-intensity conditioning and transplantation of human leukocyte antigen (HLA) -haploidentical related donor stem cells for patients with hematopoietic cell transplantation Comorbidity Index (HCT-CI) ≤2 aged ≥55 and \< 65 years old.
GVHD Prophylaxis: - Cyclophosphamide (Cy)
* Tacrolimus (Tac)
* Mycophenolate mofetil (MMF)
Haplo HCT ≥55 and \< 65 years old: - Fludarabine (Flu)
* Cyclophosphamide (Cy)
* Melphalan (Mel)
* Total body irradiation (TBI)
* non-T-cell depleted donor bone marrow stem cells
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
8
Other Number Affected:
6
Other Number At Risk:
8
Study:
NCT02988466
Results Section:
NCT02988466
Adverse Events Module:
NCT02988466